Literature DB >> 33348919

Oxidative DNA Damage, Inflammatory Signature, and Altered Erythrocytes Properties in Diamond-Blackfan Anemia.

Katarina Kapralova1, Ondrej Jahoda1, Pavla Koralkova1, Jan Gursky1, Lucie Lanikova2, Dagmar Pospisilova3, Vladimir Divoky1, Monika Horvathova1.   

Abstract

Molecular pathophysiology of Diamond-Blackfan anemia (DBA) involves disrupted erythroid-lineage proliferation, differentiation and apoptosis; with the activation of p53 considered as a key component. Recently, oxidative stress was proposed to play an important role in DBA pathophysiology as well. CRISPR/Cas9-created Rpl5- and Rps19-deficient murine erythroleukemia (MEL) cells and DBA patients' samples were used to evaluate proinflammatory cytokines, oxidative stress, DNA damage and DNA damage response. We demonstrated that the antioxidant defense capacity of Rp-mutant cells is insufficient to meet the greater reactive oxygen species (ROS) production which leads to oxidative DNA damage, cellular senescence and activation of DNA damage response signaling in the developing erythroblasts and altered characteristics of mature erythrocytes. We also showed that the disturbed balance between ROS formation and antioxidant defense is accompanied by the upregulation of proinflammatory cytokines. Finally, the alterations detected in the membrane of DBA erythrocytes may cause their enhanced recognition and destruction by reticuloendothelial macrophages, especially during infections. We propose that the extent of oxidative stress and the ability to activate antioxidant defense systems may contribute to high heterogeneity of clinical symptoms and response to therapy observed in DBA patients.

Entities:  

Keywords:  8-oxoguanine; DNA damage response; Diamond-Blackfan anemia; erythrocyte lifespan; inflammatory cytokines; reactive oxygen species

Mesh:

Substances:

Year:  2020        PMID: 33348919      PMCID: PMC7768356          DOI: 10.3390/ijms21249652

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  70 in total

1.  Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

Authors:  L G Corral; P A Haslett; G W Muller; R Chen; L M Wong; C J Ocampo; R T Patterson; D I Stirling; G Kaplan
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

2.  Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.

Authors:  Mikael S Lindström; Aiwen Jin; Chad Deisenroth; Gabrielle White Wolf; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

Review 3.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

4.  Comparison of serum and cell-specific cytokines in humans.

Authors:  J Jason; L K Archibald; O C Nwanyanwu; M G Byrd; P N Kazembe; H Dobbie; W R Jarvis
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

5.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

6.  Inflammation and p53: A Tale of Two Stresses.

Authors:  Andrei V Gudkov; Katerina V Gurova; Elena A Komarova
Journal:  Genes Cancer       Date:  2011-04

7.  Dissecting the transcriptional phenotype of ribosomal protein deficiency: implications for Diamond-Blackfan Anemia.

Authors:  Anna Aspesi; Elisa Pavesi; Elisa Robotti; Rossella Crescitelli; Ilenia Boria; Federica Avondo; Hélène Moniz; Lydie Da Costa; Narla Mohandas; Paola Roncaglia; Ugo Ramenghi; Antonella Ronchi; Stefano Gustincich; Simone Merlin; Emilio Marengo; Steven R Ellis; Antonia Follenzi; Claudio Santoro; Irma Dianzani
Journal:  Gene       Date:  2014-05-15       Impact factor: 3.688

8.  The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia.

Authors:  Nadia Danilova; Elena Bibikova; Todd M Covey; David Nathanson; Elizabeth Dimitrova; Yoan Konto; Anne Lindgren; Bertil Glader; Caius G Radu; Kathleen M Sakamoto; Shuo Lin
Journal:  Dis Model Mech       Date:  2014-05-08       Impact factor: 5.758

9.  Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network.

Authors:  Abbas Khan; Arif Ali; Muhammad Junaid; Chang Liu; Aman Chandra Kaushik; William C S Cho; Dong-Qing Wei
Journal:  BMC Syst Biol       Date:  2018-04-24

10.  The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.

Authors:  Kim R Kampen; Sergey O Sulima; Benno Verbelen; Tiziana Girardi; Stijn Vereecke; Gianmarco Rinaldi; Jelle Verbeeck; Joyce Op de Beeck; Anne Uyttebroeck; Jules P P Meijerink; Anthony V Moorman; Christine J Harrison; Pieter Spincemaille; Jan Cools; David Cassiman; Sarah-Maria Fendt; Pieter Vermeersch; Kim De Keersmaecker
Journal:  Leukemia       Date:  2018-06-21       Impact factor: 11.528

View more
  3 in total

Review 1.  Proteostasis Perturbations and Their Roles in Causing Sterile Inflammation and Autoinflammatory Diseases.

Authors:  Jonas Johannes Papendorf; Elke Krüger; Frédéric Ebstein
Journal:  Cells       Date:  2022-04-22       Impact factor: 7.666

Review 2.  Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature.

Authors:  Valentina Giudice; Chiara Cardamone; Massimo Triggiani; Carmine Selleri
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

Review 3.  Effect of Glucocorticosteroids in Diamond-Blackfan Anaemia: Maybe Not as Elusive as It Seems.

Authors:  Zuzana Macečková; Agáta Kubíčková; Juan Bautista De Sanctis; Marian Hajdúch
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.